MARKET

TXG

TXG

10X Genomics, Inc.
NASDAQ
26.90
-0.62
-2.25%
After Hours: 26.50 -0.4 -1.49% 16:31 04/25 EDT
OPEN
26.93
PREV CLOSE
27.52
HIGH
27.14
LOW
26.30
VOLUME
1.07M
TURNOVER
0
52 WEEK HIGH
63.57
52 WEEK LOW
26.30
MARKET CAP
3.21B
P/E (TTM)
-12.3548
1D
5D
1M
3M
1Y
5Y
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
NASDAQ · 1d ago
10x Genomics (TXG) Expected to Beat Earnings Estimates: Should You Buy?
NASDAQ · 2d ago
Geopolitical Relief Triggers Gold Selloff: Prices Dip Below $2,350 Mark, Mining Stocks Hit Hard
Gold prices declined 2.7% Monday to below $2,350 as geopolitical risks wane. Silver, closely associated with gold, experienced its most substantial drop since last October. Plummeting gold prices weighed on mining stocks, with the VanEck Gold Miners ETF witnessing a 4.3% decline.
Benzinga · 3d ago
Weekly Report: what happened at TXG last week (0415-0419)?
Weekly Report · 3d ago
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update
Seeking Alpha · 6d ago
The Analyst Landscape: 4 Takes On 10x Genomics
4 analysts have published ratings on 10x Genomics (NASDAQ:TXG) in the last three months. The company is a life science technology company based in the United States. Analysts have set 12-month price targets of $54.5 with an average target of $63.00 for the company. The average price target is a 4.39% decrease from the previous target.
Benzinga · 04/18 17:00
10x Genomics Is Maintained at Buy by Deutsche Bank
Dow Jones · 04/18 12:23
10x Genomics Price Target Cut to $55.00/Share From $60.00 by Deutsche Bank
Dow Jones · 04/18 12:23
More
About TXG
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Webull offers 10X Genomics Inc stock information, including NASDAQ: TXG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXG stock methods without spending real money on the virtual paper trading platform.